Demand for COVID tests has fluctuated during the course of the pandemic and Abbott has recently seen demand decline for its BinaxNOW rapid antigen tests. In the first quarter, the company reported ...
Assay identifies HIV p24 antigen and antibodies to HIV-1 group M and group O and/or HIV-2. FDA has approved Abbott’s Architect HIV Ag/Ab Combo assay for the simultaneous detection of both HIV antigen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results